| Overview |
| bsm-61515r-pe-cy7 |
| BNIP3L Recombinant Antibody, PE-Cy7 Conjugated |
| WB |
| Human |
| Specifications |
| PE-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human BNIP3L |
| Recombinant |
| #REF! |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 665 |
| O60238 |
| Cytoplasm, Nucleus, Cell membrane |
| Adenovirus E1B19k binding protein B5; BNIP3a; BNIP3H; BNIP3L; BNIP3L protein; NIP3 like protein X; NIP3L; NIX. |
| Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz